• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在美国,不同种族和族裔群体的甲状腺乳头状癌发病率增长速度相似。

The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.

机构信息

Department of Health Studies, University of Chicago, Chicago, IL, USA.

出版信息

Ann Surg Oncol. 2013 Aug;20(8):2746-53. doi: 10.1245/s10434-013-2892-y. Epub 2013 Mar 17.

DOI:10.1245/s10434-013-2892-y
PMID:23504142
Abstract

BACKGROUND

Reports of similar age-specific incidence rates and a female-to-male gender disparity by racial/ethnic groups suggests that further consideration of race-specific patterns may confer insight into the possible causes of thyroid cancer or explanations for the increase in incidence.

METHODS

We used the National Cancer Institute's (NCIs) surveillance, epidemiology, and end results (SEER) program and Joinpoint Regression for cases diagnosed during 1992-2009 to investigate trends and rates of acceleration for papillary thyroid cancer by gender and race/ethnicity.

RESULTS

We determined the annual percent change (APC) and found a yearly increase of 7.0 % for papillary thyroid cancer for the most recent APC trend, with an APC of 6.3 and 7.1 % for white males and females, respectively; an APC of 4.3 and 8.4 % for black males and females, respectively; an APC of 4.2 and 6.7 % for Hispanic males and females, respectively; and an APC of 3.4 and 6.4 % in Asian/PI males and females, respectively. The APC projections show the rates of papillary thyroid cancer rising in males, but the patterns are more dramatic in females, with rates of papillary thyroid cancer in females surpassing rates of common cancers and becoming the third most common cancer in women of all ages by 2019.

CONCLUSIONS

Although the lowest rates of thyroid cancer are observed in blacks, the greatest rate of acceleration is occurring in black females. Our data also show that the rate of papillary thyroid cancer will continue to surpass rates of ovarian cancer, and in white women: it is projected to be more incident than colorectal cancer as well; and in Hispanic and Asian/Pacific Islander women, rates of papillary thyroid cancer are projected to be higher than lung, colorectal, and ovarian cancers in the near future.

摘要

背景

按种族/民族划分,报告的相似年龄特异性发病率和男女性别差异表明,进一步考虑种族特异性模式可能有助于深入了解甲状腺癌的可能病因或发病率增加的解释。

方法

我们使用美国国家癌症研究所(NCI)的监测、流行病学和最终结果(SEER)计划和 Joinpoint 回归,分析了 1992-2009 年期间诊断出的病例,以调查性别和种族/民族对甲状腺乳头状癌的趋势和加速率。

结果

我们确定了年度百分比变化(APC),发现最近的 APC 趋势中甲状腺乳头状癌每年增加 7.0%,白种男性和女性的 APC 分别为 6.3%和 7.1%;黑种男性和女性的 APC 分别为 4.3%和 8.4%;西班牙裔男性和女性的 APC 分别为 4.2%和 6.7%;亚洲/太平洋岛民男性和女性的 APC 分别为 3.4%和 6.4%。APC 预测显示,男性甲状腺乳头状癌的发病率正在上升,但女性的模式更为明显,到 2019 年,女性甲状腺乳头状癌的发病率超过常见癌症,成为所有年龄段女性中第三大常见癌症。

结论

尽管黑人的甲状腺癌发病率最低,但加速率最高的是黑人女性。我们的数据还表明,甲状腺乳头状癌的发病率将继续超过卵巢癌的发病率,在白人女性中:预计它将比结直肠癌更常见;在西班牙裔和亚洲/太平洋岛民女性中,在不久的将来,甲状腺乳头状癌的发病率预计将高于肺癌、结直肠癌和卵巢癌。

相似文献

1
The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.在美国,不同种族和族裔群体的甲状腺乳头状癌发病率增长速度相似。
Ann Surg Oncol. 2013 Aug;20(8):2746-53. doi: 10.1245/s10434-013-2892-y. Epub 2013 Mar 17.
2
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.美国 1992-2006 年按组织学类型划分的甲状腺癌发病模式。
Thyroid. 2011 Feb;21(2):125-34. doi: 10.1089/thy.2010.0021. Epub 2010 Dec 27.
3
Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.1997-2008 年巴西圣保罗和美国 SEER 项目甲状腺癌发病模式。
Thyroid. 2013 Jun;23(6):748-57. doi: 10.1089/thy.2012.0532. Epub 2013 May 28.
4
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.1980 - 2005年美国按人口统计学和肿瘤特征划分的甲状腺癌发病率上升情况
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):784-91. doi: 10.1158/1055-9965.EPI-08-0960. Epub 2009 Feb 24.
5
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.1988 - 2005年美国分化型甲状腺癌发病率上升
Cancer. 2009 Aug 15;115(16):3801-7. doi: 10.1002/cncr.24416.
6
The effects of race and ethnicity on thyroid cancer incidence.种族和族裔对甲状腺癌发病率的影响。
JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):319-23. doi: 10.1001/jamaoto.2014.3740.
7
Follicular thyroid cancer incidence patterns in the United States, 1980-2009.美国滤泡性甲状腺癌发病率模式:1980-2009 年。
Thyroid. 2013 Aug;23(8):1015-21. doi: 10.1089/thy.2012.0356. Epub 2013 Jul 20.
8
Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.2010 年至 2016 年美国按年龄和种族/族裔划分的乳腺癌分子亚型发病趋势。
JAMA Netw Open. 2020 Aug 3;3(8):e2013226. doi: 10.1001/jamanetworkopen.2020.13226.
9
Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001.1992 - 2001年按结直肠癌发病部位、诊断时分期及种族/族裔划分的长期变化情况
Cancer. 2006 Sep 1;107(5 Suppl):1142-52. doi: 10.1002/cncr.22011.
10
Recent incidences and differential trends of thyroid cancer in the USA.美国甲状腺癌的近期发病率及差异趋势。
Endocr Relat Cancer. 2016 Apr;23(4):313-22. doi: 10.1530/ERC-15-0445. Epub 2016 Feb 25.

引用本文的文献

1
Epidemiological study of thyroid cancer at global, regional, and national levels from 1990 to 2021: an analysis derived from the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家层面甲状腺癌的流行病学研究:基于《2021年全球疾病负担研究》的分析
Front Endocrinol (Lausanne). 2025 Aug 26;16:1644270. doi: 10.3389/fendo.2025.1644270. eCollection 2025.
2
Diagnostic sensitivity of fine-needle aspiration cytology in thyroid cancer.细针穿刺细胞学诊断在甲状腺癌中的敏感性。
Sci Rep. 2024 Oct 16;14(1):24216. doi: 10.1038/s41598-024-75677-7.
3
Long-term trends in cancer incidence and mortality among U.S. children and adolescents: a SEER database analysis from 1975 to 2018.
美国儿童和青少年癌症发病率及死亡率的长期趋势:一项基于监测、流行病学和最终结果(SEER)数据库的1975年至2018年分析
Front Pediatr. 2024 Jul 5;12:1357093. doi: 10.3389/fped.2024.1357093. eCollection 2024.
4
Impact of fine-needle aspiration cytology in thyroidectomy extent and associated surgical morbidity in thyroid cancer.细针穿刺细胞学检查对甲状腺癌甲状腺切除范围及相关手术并发症的影响
Langenbecks Arch Surg. 2024 Feb 19;409(1):68. doi: 10.1007/s00423-024-03258-3.
5
Machine learning for risk stratification of thyroid cancer patients: a 15-year cohort study.用于甲状腺癌患者风险分层的机器学习:一项15年队列研究。
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):2095-2104. doi: 10.1007/s00405-023-08299-w. Epub 2023 Oct 30.
6
Advances in Molecular Profiling and Their Potential Influence on the Extent of Surgery in Well-Differentiated Thyroid Carcinoma (WDTC).分子剖析的进展及其对高分化甲状腺癌(WDTC)手术范围的潜在影响
Life (Basel). 2023 Jun 13;13(6):1382. doi: 10.3390/life13061382.
7
Identification of KIT and BRAF mutations in thyroid tissue using next-generation sequencing in an Ecuadorian patient: A case report.在一名厄瓜多尔患者中使用下一代测序技术鉴定甲状腺组织中的KIT和BRAF突变:病例报告
Front Oncol. 2023 Jan 17;12:1101530. doi: 10.3389/fonc.2022.1101530. eCollection 2022.
8
Identification of R-Spondin Gene Signature Predictive of Metastatic Progression in BRAFV-Positive Papillary Thyroid Cancer.鉴定 R-Spondin 基因特征可预测 BRAFV 阳性甲状腺乳头状癌的转移进展。
Cells. 2022 Dec 29;12(1):139. doi: 10.3390/cells12010139.
9
Surgery and Radioactive Iodine Therapeutic Strategy for Patients Greater Than 60 Years of Age with Differentiated Thyroid Cancer.对于年龄大于 60 岁的分化型甲状腺癌患者,手术和放射性碘治疗策略。
J Healthc Eng. 2022 Feb 8;2022:4348396. doi: 10.1155/2022/4348396. eCollection 2022.
10
The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: A systematic analysis for the Global Burden of Disease Study.全球 195 个国家和地区的甲状腺癌发病负担及其归因风险因素:全球疾病负担研究的系统分析。
Cancer Med. 2021 Jul;10(13):4542-4554. doi: 10.1002/cam4.3970. Epub 2021 May 18.